Priority Date: 28.06.12 (EP 20120174020)

DESIGNED ANKYRIN REPEAT PROTEINS BINDING TO PLATELET-DERIVED GROWTH FACTOR

  • Application ID: EP13731809
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 1 - 10 employees
Company dna latscha schollhorn partner ag
operating since 2012
Headquarter in Basel
active in Legal Services

Specialization

This EP application has the IPC class C07, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 57 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 28.06.2012 - Priority Date (EP 20120174020)
  • 03.01.2014 - Publication A1 (WO2014001442)
  • 06.05.2015 - Publication A1 (EP2867360)